Kelly Magee Riley

Title: Kelly Magee Riley: Innovator in Pharmaceutical Technology

Introduction

Kelly Magee Riley is a prominent inventor based in Cary, NC (US). She has made significant contributions to the field of pharmaceutical technology, particularly in the development of devices aimed at improving insulin delivery systems.

Latest Patents

Kelly Magee Riley holds 1 patent for her innovative work titled "Filter for reducing phenolic compounds from insulin and related infusion and injection devices." This patent describes devices, systems, and methods designed to remove preservatives, excipients, and stabilizers from pharmaceutical preparations. The technology includes a resin that effectively filters out preservatives while maintaining the necessary concentration of active compounds in the preparation. Additionally, her work encompasses methods for the controlled release of anti-inflammatory agents in insulin infusion sets.

Career Highlights

Kelly is currently employed at Becton Dickinson and Company Limited, where she continues to advance her research and development efforts in the pharmaceutical sector. Her work is crucial in enhancing the safety and efficacy of insulin delivery systems.

Collaborations

Throughout her career, Kelly has collaborated with notable colleagues, including Matthew Novak and Alfred Joseph Harvey. These partnerships have contributed to the success of her projects and innovations.

Conclusion

Kelly Magee Riley exemplifies the spirit of innovation in the pharmaceutical industry, with her groundbreaking patent addressing critical challenges in insulin delivery systems. Her contributions are paving the way for safer and more effective medical treatments.